MC1053A1 - Medicament comprenant une 2,4-diamino-pyrimidine er un sulfonamide t un sulfonamide - Google Patents

Medicament comprenant une 2,4-diamino-pyrimidine er un sulfonamide t un sulfonamide

Info

Publication number
MC1053A1
MC1053A1 MC751136A MC1136A MC1053A1 MC 1053 A1 MC1053 A1 MC 1053A1 MC 751136 A MC751136 A MC 751136A MC 1136 A MC1136 A MC 1136A MC 1053 A1 MC1053 A1 MC 1053A1
Authority
MC
Monaco
Prior art keywords
tablet according
sulfonamide
weight
tablet
diaminopyrimidine
Prior art date
Application number
MC751136A
Other languages
English (en)
French (fr)
Inventor
A J Torode
D Harden
J Spence
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9820242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MC1053(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1053A1 publication Critical patent/MC1053A1/fr
Priority to MC1136K priority Critical patent/MC181A7/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MC751136A 1974-02-14 1975-02-13 Medicament comprenant une 2,4-diamino-pyrimidine er un sulfonamide t un sulfonamide MC1053A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MC1136K MC181A7 (fr) 1974-02-14 1976-04-09 Medicament comprenant une 2,4-diamino-pyrimidine e

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6758/74A GB1499672A (en) 1974-02-14 1974-02-14 Tablet formulation

Publications (1)

Publication Number Publication Date
MC1053A1 true MC1053A1 (fr) 1976-02-20

Family

ID=9820242

Family Applications (1)

Application Number Title Priority Date Filing Date
MC751136A MC1053A1 (fr) 1974-02-14 1975-02-13 Medicament comprenant une 2,4-diamino-pyrimidine er un sulfonamide t un sulfonamide

Country Status (32)

Country Link
JP (1) JPS5545043B2 (cs)
AT (1) AT344915B (cs)
AU (1) AU468465B2 (cs)
BE (1) BE825496A (cs)
CA (1) CA980688A (cs)
CH (1) CH618432A5 (cs)
CS (1) CS220306B2 (cs)
CY (1) CY1052A (cs)
DD (1) DD118228A5 (cs)
DE (1) DE2506099C2 (cs)
DK (1) DK143247C (cs)
DO (1) DOP1979002763A (cs)
ES (1) ES434688A1 (cs)
FI (1) FI62219C (cs)
FR (1) FR2260993B1 (cs)
GB (1) GB1499672A (cs)
GT (1) GT197960431A (cs)
HK (1) HK23980A (cs)
HU (1) HU171536B (cs)
IE (1) IE40599B1 (cs)
IL (1) IL46629A (cs)
IN (1) IN141019B (cs)
KE (1) KE3038A (cs)
LU (1) LU71835A1 (cs)
MC (1) MC1053A1 (cs)
MY (1) MY8100054A (cs)
NL (1) NL157501C (cs)
NO (1) NO146043C (cs)
PH (1) PH14575A (cs)
SE (1) SE427898B (cs)
ZA (1) ZA75930B (cs)
ZM (1) ZM1875A1 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
JP2022184789A (ja) * 2021-05-31 2022-12-13 国立研究開発法人国立成育医療研究センター スルファメトキサゾール及びトリメトプリムを含有する小型錠剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1445983A (en) * 1972-11-06 1976-08-11 Wellcome Found Pharmaceutical formulations

Also Published As

Publication number Publication date
FI62219B (fi) 1982-08-31
PH14575A (en) 1981-09-24
DK52875A (cs) 1975-10-06
HU171536B (hu) 1978-01-28
MY8100054A (en) 1981-12-31
AU7817075A (en) 1976-01-15
SE7501595L (cs) 1975-08-15
DE2506099A1 (de) 1975-08-21
JPS5545043B2 (cs) 1980-11-15
DD118228A5 (cs) 1976-02-20
HK23980A (en) 1980-05-09
FR2260993B1 (cs) 1978-06-30
KE3038A (en) 1980-04-25
IN141019B (cs) 1977-01-08
GB1499672A (en) 1978-02-01
IL46629A0 (en) 1975-05-22
CY1052A (en) 1980-08-01
FI750398A7 (cs) 1975-08-15
DK143247B (da) 1981-08-03
DE2506099C2 (de) 1983-11-03
DK143247C (da) 1981-11-30
FI62219C (fi) 1982-12-10
JPS50116627A (cs) 1975-09-12
CH618432A5 (en) 1980-07-31
ATA108475A (de) 1977-12-15
CA980688A (en) 1975-12-30
NO146043B (no) 1982-04-13
ZM1875A1 (en) 1975-12-22
IE40599B1 (en) 1979-07-04
AT344915B (de) 1978-08-25
GT197960431A (es) 1981-05-05
DOP1979002763A (es) 1987-06-18
ES434688A1 (es) 1977-04-01
NO146043C (no) 1982-08-04
IL46629A (en) 1977-07-31
NL157501B (nl) 1978-08-15
NO750467L (cs) 1975-08-15
AU468465B2 (en) 1976-01-15
NL157501C (nl) 1981-07-16
NL7501680A (nl) 1975-08-18
ZA75930B (en) 1976-01-28
SE427898B (sv) 1983-05-24
BE825496A (fr) 1975-05-29
FR2260993A1 (cs) 1975-09-12
CS220306B2 (en) 1983-03-25
LU71835A1 (cs) 1975-06-24
IE40599L (en) 1975-08-14

Similar Documents

Publication Publication Date Title
Ramachandran et al. Formulation and characterization of glutaraldehyde cross-linked chitosan biodegradable microspheres loaded with famotidine
CN104382868B (zh) 口腔可分散的甘露醇
JPS6011414A (ja) 粒状ｎ−アセチル−ｐ−アミノフエノ−ル組成物およびその製造方法
Katsuno et al. Orally disintegrating tablets prepared by a co-processed mixture of micronized crospovidone and mannitol using a ball mill to improve compactibility and tablet stability
Liso et al. Analysis of the leaching and toxicity of new amine activators for the curing of acrylic bone cements and composites
EA002625B1 (ru) Матричная таблетка, позволяющая пролонгировать выход гликлазида после орального приема
EA028432B1 (ru) Новые составы на основе (триметоксифениламино)пиримидинилов
US5470580A (en) Directly-compressible naproxen or naproxen sodium compositions
FI62219C (fi) Foerfarande foer framstaellning av snabbt soenderfallande tabletter
US4086335A (en) Pharmaceutical tablets containing chitin as a disintegrant
BE838506R (fr) Comprimes contenant une combinaison d'une 2,4-diaminopyrimidine avec un sulfonamide
CN112546018A (zh) 一种头孢克洛胶囊剂及其制备方法
IE42952B1 (en) Tablet formulation
Thakare Eknath et al. Formulation and evaluation of mucoadhesive buccal tablet of repaglinide
CN1476898A (zh) 口服给药后能延长释放的治疗感冒复方骨架片
DK144261C (da) Medicinsk tablet indeholdende allopurinol
Patil et al. Formulation and in vitro Evaluation of Matrix tablets containing Repaglinide
Majekodunmi et al. Development of Novel Drug Delivery System Using Calcium Silicate
Adeyanju et al. Toxicological Studies and Utilization of Daniella Oliveri Gum as Binder in Drug Formulation
Gharge et al. Formulation and evaluation of microencapsulated Glimepiride produced by the emulsion-solvent evaporation method
Al-Pokhiti et al. Development and evaluation of sustained release matrix tablets of ketoprofen employing natural polymers (pomegranate peel and acacia powders)
RU2836886C1 (ru) Способ получения гастроретентивных флотирующих таблеток ситаглиптина (варианты)
Yadav et al. Formulation and Evaluation of Gastroretentive Floating Tablets of Clopidogrel Bisulphate
Akhter et al. Comparative study on formulation and evaluation of fast dissolving Glibenclamide tablets: Opportunity in drug delivery system
Mir Formulation And Characterization Of A New Gastrointestinal Drug Delivery System Of Cinnarizine Hydrochloride

Legal Events

Date Code Title Description
YP Annual fee paid